![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, May 25, 2024 10:07:30 AM
How many will NEED a prescription because of ifs severity? It the $2 Billion market 'estimate' based on everyone going thru
chemo being given a prescription or is that number based on those that NEED something? Like over the counter, or a dietary change
vs a heavy duty medicine like what Jagx is developing?
For from what I can tell, while there is a need, the 2nd link below estimates are far below the $2 Bil mark by a factor of 20?? And even if
JAGs product captures a 100% of the 'needed' market? Are we talking about less than $150 Million in sales?? (ie, what Jag sells simply replaces
everything else being sold??)
This is why my MARKET CAP estimate is $50 Mil at best, with the share count at around 5 Mil, giving me a target price of $10/sh??
Disclaimer: I am very conservative in my estimates till proven wrong by the companys actuals which we don't have any of at the moment.. and
note, I have no idea what to believe with respect to the potential market $ which is why I have been asking what others are using, seeing..
https://www.medicalnewstoday.com/articles/chemo-diarrhea#treatment
Diarrhea is usually a relatively minor chemo side effect, but some peopleTrusted Source experience severe diarrhea. In some cases, diarrhea can also be life threatening. This is because severe dehydration can causeTrusted Source organ damage and even death.
https://www.imarcgroup.com/chemotherapy-induced-diarrhea-market
Report Attribute
Key Statistics
Base Year 2023
Forecast Years 2024-2034
Historical Years
2018-2023
Market Size in 2023
US$ 84.5 Million
Market Forecast in 2034
US$ 153.1 Million
Market Growth Rate 2024-2034
5.55%
Recent JAGX News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 04:19:15 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/31/2024 10:30:50 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 05/28/2024 10:03:46 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 10:20:41 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/23/2024 10:05:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 09:04:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 09:03:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 09:02:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2024 09:01:25 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/21/2024 01:02:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 10:41:41 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/10/2024 09:07:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 10:00:33 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/05/2024 12:00:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 10:30:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:13:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 10:25:44 PM
- FILAMENT HEALTH ANNOUNCES THIRD QUARTER 2023 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS • PR Newswire (Canada) • 11/15/2023 02:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 10:03:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 09:03:29 PM
- FILAMENT HEALTH AND JAGUAR HEALTH JOINT VENTURE MAGDALENA BIOSCIENCES COMPLETES IMPORT OF COCA LEAF FROM PERU • PR Newswire (Canada) • 09/21/2023 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2023 08:55:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2023 08:53:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2023 08:50:14 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM